BIOMEDICAL RESEARCH MODELS, INC.

Basic Information

67 MILLBROOK, ST, STE 422
WORCESTER, MA, 01606-2845

Company Profile

n/a

Additional Details

Field Value
DUNS: 15341134
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Advancing a Mucosal HSV-2 Vaccine Towards Clinical Trials

    Amount: $2,999,168.00

    DESCRIPTION (provided by applicant): Globally, an estimated 16.2% of the human population is infected with HSV-2 including gt17% of the U.S. adult population. Genital herpes is associated with an incr ...

    SBIR Phase II 2014 Department of Health and Human Services
  2. A Mucosal RSV Vaccine

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Human respiratory syncytial virus (RSV) is a highly infectious member of the paramyxovirus family causing upper and lower respiratory tract infections. RSV infecti ...

    SBIR Phase I 2012 Department of Health and Human Services
  3. Developing Small MIF Inhibitors for Rheumatoid Arthritis

    Amount: $452,431.00

    DESCRIPTION (provided by applicant): Rheumatoid arthritis is a chronic inflammatory disorder that afflicts at least 2.5 million Americans. This autoimmune disease is 2-3 times more common in women and ...

    SBIR Phase I 2012 Department of Health and Human Services
  4. Developing small molecule therapeutics for lupus

    Amount: $583,195.00

    DESCRIPTION (provided by applicant): Systemic lupus erythematosus (SLE) affects ~ 2 million Americans with devastating impact on multiple organs, especially the skin, joints, kidney, and brain. Th ...

    STTR Phase I 2011 Department of Health and Human Services
  5. New Rat Model For Autoimmune Therapy Safety/Efficacy

    Amount: $594,141.00

    DESCRIPTION (provided by applicant): Autoimmune diseases comprise the third most common category of illness in the United States affecting an estimated 22 million Americans. To date, therapeutic and ...

    SBIR Phase I 2010 Department of Health and Human Services
  6. A Mucosal Vaccine for HSV-2

    Amount: $2,563,533.00

    DESCRIPTION (provided by applicant): Approximately 1 out of every 5 Americans is infected with herpes simplex virus type 2 (HSV-2). Localized genital infection by HSV-2 results in painful recurring ge ...

    SBIR Phase II 2009 Department of Health and Human Services
  7. A Mucosal Vaccine for HSV-2

    Amount: $583,103.00

    DESCRIPTION (provided by applicant): Approximately 1 out of every 5 Americans is infected with herpes simplex virus type 2 (HSV-2). Localized genital infection by HSV-2 results in painful recurring ...

    SBIR Phase I 2006 Department of Health and Human Services
  8. Engineering Myoblasts for Transplantation

    Amount: $223,141.00

    DESCRIPTION (provided by applicant): The primary goals of stem cell biology are to develop practical cell-based tools: 1) to enhance the repair of damaged organs and tissues; and 2) as vehicles for ge ...

    STTR Phase I 2004 Department of Health and Human Services
  9. New Model For Virus Induced Autoimmunity

    Amount: $319,761.00

    DESCRIPTION (provided by applicant): The objective of this program is to validate a new animal model for virus-initiated autoimmunity using our colony of congenic Lew.IWR1 rats. Preliminary data demon ...

    STTR Phase I 2004 Department of Health and Human Services
  10. In-Stent Stenosis Model in Type 2 Diabetic Rats

    Amount: $393,589.00

    DESCRIPTION (provided by applicant): Coronary artery disease affects 12 million Americans and is the number on killer in the United States. Diabetes affects over 16 million Americans, with more tha ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government